Skip to main content

Ménière’s Disease with Concomitant Vestibular Migraine

  • Chapter
  • First Online:
Vestibular Migraine

Abstract

Up to a quarter of Ménière’s disease (MD) patients can present with concomitant vestibular migraine (VM). If one considers MD patients with migrainous features who do not meet VM criteria, over half of MD patients may have migraine playing some role in symptom presentation or etiology. This chapter will focus on this difficult and often treatment-resistant patient category of Ménière’s disease with concomitant vestibular migraine (MDVM).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Atkinson M. Migraine and Ménière’s disease. Arch Otolaryngol. 1962;75:220–5.

    Article  CAS  PubMed  Google Scholar 

  2. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107:1123–42.

    Article  PubMed  Google Scholar 

  3. Neff BA, Staab JP, Carlson ML, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33:1235–44.

    Article  PubMed  Google Scholar 

  4. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. Otolaryngol Head Neck Surg. 1995;113:181–5.

    Google Scholar 

  5. Wladislavosky-Waserman P, Facer GW, Mokri B, et al. Ménière’s disease: a 30-year epidemiologic & clinical study in Rochester, MN, 1951-80. Laryngoscope. 1984;94(8):1098–102.

    Article  CAS  PubMed  Google Scholar 

  6. Vrbec JT. Genetic investigations of Ménière’s disease. Otolaryngol Clin North Am. 2010;43(5):1121–32.

    Article  Google Scholar 

  7. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of healthcare use. Neurology. 2002;58(6):885–94.

    Article  CAS  PubMed  Google Scholar 

  8. Sargent EW. The challenge of vestibular migraine. Curr Opin Otolaryngol Head Neck Surg. 2013;21:473–9.

    Article  PubMed  Google Scholar 

  9. von Brevern M, Neuhauser H. Epidemiological evidence for a link between vertigo and migraine. J Vestib Res. 2011;21:299–304.

    Google Scholar 

  10. Eggers SDZ, Staab JP, Neff BA, et al. Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol. 2011;32:1144–51.

    Article  PubMed  Google Scholar 

  11. Radtke A, Lempert T, Gresty MA, et al. Migraine and Ménière’s disease, is there a link? Neurology. 2002;59:1700–4.

    Article  CAS  PubMed  Google Scholar 

  12. Shepard NT. Differentiation of Ménière’s disease and migraine-associated dizziness: a review. J Am Acad Audiol. 2006;17:69–80.

    Article  PubMed  Google Scholar 

  13. Ibekwe TS, Fasunla JA, Ibekwe PU, et al. Migraine and Ménière’s disease: two different phenomena with frequently observed concomitant occurrences. J Natl Med Assoc. 2008;100(3):334–8.

    PubMed  Google Scholar 

  14. Cha YH, Kane MJ, Baloh RW. Familial clustering of migraine, episodic vertigo, and Ménière’s disease. Otol Neurotol. 2008;29(1):93–6.

    Article  PubMed Central  PubMed  Google Scholar 

  15. International Headache Society Classification Subcommittee. International classification of headache disorders. 2nd ed. Cephalalgia. 2004;24 Suppl 1:1–160.

    Google Scholar 

  16. Olsson JE. Neurotologic findings in basilar migraine. Laryngoscope. 1991;101(1 Pt 2 Suppl 52):1–41.

    CAS  PubMed  Google Scholar 

  17. Karatas M. Vascular vertigo: epidemiology and clinical syndromes. Neurologist. 2011;17:1–10.

    Article  PubMed  Google Scholar 

  18. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.

    Article  PubMed  Google Scholar 

  19. Peng KP, Fuh JL, Wang SJ. High-pressure headaches: idiopathic intracranial hypertension and its mimics. Nat Rev Neurol. 2012;8(12):700–12.

    Article  CAS  PubMed  Google Scholar 

  20. Ishiyama G, Ishiyama A. Vertebrobasilar infarcts and ischemia. Otolaryngol Clin North Am. 2011;44:415–35.

    Article  PubMed  Google Scholar 

  21. Lee HK, Ahn SK, Jeon SY, et al. Clinical characteristics and natural course of recurrent vestibulopathy: a long-term follow-up study. Laryngoscope. 2012;122(4):883–6.

    Article  PubMed  Google Scholar 

  22. Cha YH, Lee H, Santell LS, et al. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia. 2009;29(5):550–7.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Hallpike C, Cairns H. Observations on the pathology of Ménière’s syndrome. J Laryngol Otol. 1938;53:625–54.

    Article  Google Scholar 

  24. Foster CA, Breeze RE. Endolymphatic hydrops in Ménière’s disease: cause, consequence, or epiphenomenon. Otol Neurotol. 2013;34:1210–4.

    Article  PubMed  Google Scholar 

  25. Lee H, Lopez I, Ishiyami A, et al. Can migraine damage the inner ear? Arch Neurol. 2000;57:1631–4.

    CAS  PubMed  Google Scholar 

  26. Kimura R. Experimental endolymphatic hydrops. In: Harris JP, editor. Ménière’s disease. The Hague: Kugler publications; 1999. p. 115–24.

    Google Scholar 

  27. Gates P. Hypothesis: could Ménière’s disease be a channelopathy? Intern Med J. 2005;35:488–9.

    Article  CAS  PubMed  Google Scholar 

  28. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol. 2003;16:5–13.

    Article  PubMed  Google Scholar 

  29. Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12:706–15.

    Article  CAS  PubMed  Google Scholar 

  30. Koo KW, Balaban CD. Serotonin-induced plasma extravasation in the murine inner ear: possible mechanism of migraine-associated inner ear dysfunction. Cephalalgia. 2006;26:1310–9.

    Article  PubMed  Google Scholar 

  31. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300–4.

    Article  CAS  PubMed  Google Scholar 

  32. Bisdorff A, Von Brevern M, Lempert T, et al. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19:1–13.

    PubMed  Google Scholar 

  33. Neuhauser H, Lempert T. Vestibular migraine. Neurol Clin. 2009;27:379–91.

    Article  PubMed  Google Scholar 

  34. Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22:167–72.

    PubMed  Google Scholar 

  35. Strupp M, Versino M, Brandt T. Vestibular migraine. Handb Clin Neurol. 2010;97:755–71.

    Article  PubMed  Google Scholar 

  36. Wuyts FL, Van de Heyning PH, Van Spaendonck MP, et al. A review of electrocochleography: instrumentation settings and meta-analysis of criteria for diagnosis of endolymphatic hydrops. Acta Otolaryngol Suppl. 1997;526:14–20.

    Article  CAS  PubMed  Google Scholar 

  37. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998;108(1 Pt 2):1–28.

    Article  CAS  PubMed  Google Scholar 

  38. Zuniga MG, Janky KL, Schubert MC, et al. Can vestibular-evoked myogenic potentials help differentiate Ménière’s disease from vestibular migraine. Otolaryngol Head Neck Surg. 2012;145(5):788–96.

    Article  Google Scholar 

  39. Gurkov R, Katner C, Strupp M, et al. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014; 271(10):2661–7.

    Article  PubMed  Google Scholar 

  40. Lassen LF, Hirsch BE, Kamerer DB. Use of nimodipine in the medical treatment of Ménière’s disease: clinical experience. Am J Otol. 1996;17:577–80.

    CAS  PubMed  Google Scholar 

  41. Clemmens C, Ruckenstein M. Characteristics of patients with unilateral and bilateral Ménière’s disease. Otol Neurotol. 2012;33(7):1266–9.

    Article  PubMed  Google Scholar 

  42. Burgess A, Kundu S. Diuretics for Ménière’s disease or syndrome (review). Cochrane Database Syst Rev. 2006 (3):CD003599. Updated 2010, Issue 4.

    Google Scholar 

  43. James A, Burton MJ. Betahistine for Ménière’s disease or syndrome (review). Cochrane Database Syst Rev. 2001 (1):CD001873. Updated 2011, Issue 3.

    Google Scholar 

  44. Phillips JS, Westerberg B. Intratympanic steroids for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2011 (7):CD008514.

    Google Scholar 

  45. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa GR, Pane PC, Rios Castenada LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285–94.

    Article  PubMed  Google Scholar 

  46. Kim HH, Wiet RJ, Battista RA. Trends in the management of Ménière’s disease: results of a survey. Otolaryngol Head Neck Surg. 2005;132(5):72–6.

    Article  Google Scholar 

  47. Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg. 2009;17:356–62.

    Article  PubMed  Google Scholar 

  48. Shojaku H, Wantanabe Y, Yagi T, et al. Changes in the characteristics of definite Ménière’s disease over time in Japan: a long-term survey by the Peripheral Vestibular Disorder Research Committee of Japan. Acta Otolaryngol. 2009;129:155–60.

    Article  PubMed  Google Scholar 

  49. Perez R, Chen JM, Nedzelski JM. The status of the contralateral ear in established unilateral Ménière’s disease. Laryngoscope. 2004;114:1373–6.

    Article  PubMed  Google Scholar 

  50. Chaves AG, Boari L, Lei Munhoz MS. The outcome of patients with Ménière’s disease. Braz J Otorhinolaryngol. 2007;73:346–50.

    PubMed  Google Scholar 

  51. Lin MY, Timmer FC, Oriel BS, et al. Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope. 2006;116:987–92.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Holden LK, Neely JG, Gotter BD, et al. Sequential bilateral cochlear implantation in a patient with bilateral Ménière’s disease. J Am Acad Audiol. 2012;23(4):256–68.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Hansen MR, Gantz BJ, Dunn C. Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière’s disease. Otol Neurotol. 2013;34(9):1681–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian A. Neff MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Neff, B.A., Carlson, M.L. (2015). Ménière’s Disease with Concomitant Vestibular Migraine. In: Wetmore, S., Rubin, A. (eds) Vestibular Migraine. Springer, Cham. https://doi.org/10.1007/978-3-319-14550-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14550-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14549-5

  • Online ISBN: 978-3-319-14550-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics